Illustrative estimate only - not verified by this sponsor. Contact the study team for actual compensation.
This is an open-label, single center study to evaluate implementation of a pharmacist-managed delivery of L4P in a community pharmacy setting and the impact of twice-yearly vs. quarterly PrEP visits on STI rates.
What happens when you apply
Reach out via phone or email to express interest
Brief call to discuss your health history
Medical screening at the research site
Begin your journey in the study
Inclusion Criteria: * 18 years of age or older at the time of screening * weight greater than or equal to 35kg * HIV-negative status * Willing to provide informed consent and undergo all required study procedures Exclusion Criteria: * Unknown or positive HIV status * Coadministration of drugs that significantly decreases lenacapavir concentrations according to the FDA package insert * Any participant that do not meet criteria for management under the CDTA
imaguineapig pulls live data from ClinicalTrials.gov (NIH/NLM).Illustrative estimate only - not verifiedPay estimates are approximate ranges based on study type and are not confirmed by sponsors — actual compensation may differ. Eligibility indicators use limited criteria (age, sex) only. We do not provide medical advice. Always contact the study team directly to confirm compensation, full eligibility, and risks before enrolling.